5-aminopyrazole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 74561 |
| CHEMBL ID | 3217770 |
| MeSH ID | M000614085 |
| Synonym |
|---|
| AC-4837 |
| 5-aminopyrazole |
| EN300-27598 |
| BB 0241798 |
| BB 0219775 |
| 3-amino-1h-pyrazole |
| 3-aminopyrazole |
| 1h-pyrazol-3-amine |
| 1820-80-0 |
| nsc76122 |
| nsc-76122 |
| inchi=1/c3h5n3/c4-3-1-2-5-6-3/h1-2h,(h3,4,5,6 |
| 1h-pyrazol-5-amine |
| STK292780 |
| 3-aminopyrazole, 98% |
| A1859 |
| AKOS000163955 |
| 916420-28-5 |
| AKOS002657057 |
| aminopyrazole |
| 5-amino-pyrazole |
| 5-amino-1h-pyrazole |
| BBL008564 |
| 1h-pyrazol-3-ylamine |
| 3-pyrazolamine |
| pyrazol-3-ylamine |
| einecs 217-338-1 |
| nsc 76122 |
| 1h-pyrazole-5-amine |
| 114024-26-9 |
| 1h-pyrazolamine |
| FT-0600489 |
| FT-0649846 |
| AM20090067 |
| PB32063 |
| CHEMBL3217770 |
| 1225387-53-0 |
| J-504716 |
| J-504718 |
| J-504847 |
| amino pyrazole |
| 3-amino pyrazole |
| 3-amino-2h-pyrazole |
| 2h-pyrazol-3-ylamine |
| 3-amino-pyrazole |
| 3-aminopyrazol |
| 1h-pyrazole-3-amine |
| 3-amino-1h-pyrazol |
| amino-pyrazole |
| 1h-5-pyrazolamine |
| STR03100 |
| 3-aminopyrazole hydrochloride |
| Q-101973 |
| PS-9369 |
| PS-9370 |
| DTXSID00171229 |
| mfcd00005236 |
| F0001-0657 |
| mfcd08700632 |
| 2h-pyrazole-3-ylamine |
| CS-D1141 |
| BCP27171 |
| 1h-pyrazole-imine |
| AMY23077 |
| 1-h-pyrazol-5-amine |
| Q27453670 |
| SY128689 |
| Z240126818 |
| BTB7URA7K8 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (5.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (17.50) | 29.6817 |
| 2010's | 22 (55.00) | 24.3611 |
| 2020's | 9 (22.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (4.76%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 40 (95.24%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| cis-Restricted 3-aminopyrazole analogues of combretastatins: synthesis from plant polyalkoxybenzenes and biological evaluation in the cytotoxicity and phenotypic sea urchin embryo assays. Journal of natural products, Aug-23, Volume: 76, Issue: 8 | 2013 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy. Journal of medicinal chemistry, 03-28, Volume: 62, Issue: 6 | 2019 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |